Setting COVID-19 drug trials up for success
(Kyoto University) Clinical studies on drug candidates for COVID-19 may generate more robust results by ensuring randomization, early patient recruitment and treatment initiation, a new model shows.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news
More News: COVID-19 | Infectious Diseases | Study